GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,584 | -4.8% | 52,045 | +14.2% | 0.01% | 0.0% |
| Q2 2023 | $2,713 | +7.2% | 45,558 | +2.0% | 0.01% | 0.0% |
| Q1 2023 | $2,530 | +2.8% | 44,675 | +34.8% | 0.01% | -6.7% |
| Q4 2022 | $2,462 | -99.9% | 33,145 | +1.3% | 0.02% | +15.4% |
| Q3 2022 | $1,949,000 | +4.4% | 32,725 | -1.6% | 0.01% | +8.3% |
| Q2 2022 | $1,867,000 | -12.3% | 33,255 | +15.2% | 0.01% | 0.0% |
| Q1 2022 | $2,129,000 | +3.8% | 28,862 | +1.6% | 0.01% | +9.1% |
| Q4 2021 | $2,051,000 | -3.8% | 28,409 | +2.1% | 0.01% | -8.3% |
| Q3 2021 | $2,132,000 | +2.3% | 27,829 | +3.5% | 0.01% | 0.0% |
| Q2 2021 | $2,085,000 | +22.2% | 26,890 | -2.8% | 0.01% | +9.1% |
| Q1 2021 | $1,706,000 | -5.7% | 27,670 | -0.3% | 0.01% | -8.3% |
| Q4 2020 | $1,809,000 | +34.4% | 27,740 | +2.1% | 0.01% | +20.0% |
| Q3 2020 | $1,346,000 | +3.7% | 27,180 | -0.1% | 0.01% | -9.1% |
| Q2 2020 | $1,298,000 | – | 27,210 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pembroke Management, LTD | 584,085 | $43,379,993 | 4.64% |
| Sterling Investment Advisors, Ltd. | 167,023 | $12,404,798 | 4.44% |
| Ophir Asset Management Pty Ltd | 306,871 | $22,791,309 | 4.38% |
| Godshalk Welsh Capital Management, Inc. | 72,285 | $5,368,607 | 3.92% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 672,400 | $49,939,148 | 3.30% |
| Provident Investment Management, Inc. | 362,745 | $26,941,071 | 3.19% |
| XXEC, Inc. | 97,600 | $7,248 | 2.91% |
| Van Berkom & Associates Inc. | 809,945 | $60,155 | 2.58% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,424,326 | $105,784,692 | 2.38% |
| Seaport Global Advisors, LLC | 7,647 | $567,943 | 1.97% |